Exact Sciences
EXAS
#1384
Rank
S$17.04 B
Marketcap
$92.26
Share price
2.34%
Change (1 day)
-10.31%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : S$8.69 B

According to Exact Sciences's latest financial reports the company's total assets are S$8.69 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31S$8.54 B2.38%
2022-12-31S$8.34 B-7.4%
2021-12-31S$9.01 B38.46%
2020-12-31S$6.51 B38.12%
2019-12-31S$4.71 B127.07%
2018-12-31S$2.07 B159.33%
2017-12-31S$0.80 B46.71%
2016-12-31S$0.54 B5.88%
2015-12-31S$0.51 B24.7%
2014-12-31S$0.41 B122.45%
2013-12-31S$0.18 B35.42%
2012-12-31S$0.13 B9.27%
2011-12-31S$0.12 B0.95%
2010-12-31S$0.12 B243.45%
2009-12-31S$36.21 M326.99%
2008-12-31S$8.48 M-59.81%
2007-12-31S$21.1 M-42.34%
2006-12-31S$36.59 M-41.92%
2005-12-31S$63.01 M-23.84%
2004-12-31S$82.73 M40.18%
2003-12-31S$59.02 M-32.08%
2002-12-31S$86.9 M-25.6%
2001-12-31S$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
S$1.41 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.60 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
S$28.79 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$181.17 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France